For ivabradine, the usual ceiling is 7.5 mg twice daily (15 mg/day), titrated from 5 mg twice daily to keep resting heart rate near 50–60 bpm.
When people ask how much ivabradine they can take, they usually want a straight dose range and the few rules that keep them safe. This guide gives you both—clear dose limits, when to start lower, how titration works, and where special cases change the math. You’ll also see quick tables you can scan on a phone, plus plain-language pointers on food timing, missed doses, and common combo therapies.
How Much Ivabradine Is Safe Per Day—Clinical Dosing Ranges
For adults treated for symptomatic systolic heart failure with sinus rhythm and a resting heart rate at or above the usual threshold set by guidelines, prescribers start at 5 mg twice daily with food. After roughly two weeks, the dose is adjusted based on resting heart rate and tolerability. The routine upper limit is 7.5 mg twice daily.
Some adults start at 2.5 mg twice daily. That lower entry point fits people who are more prone to slow heart rate, have conduction concerns, or are sensitive to heart-rate-lowering drugs. The dose then steps up in small increments as long as resting heart rate and symptoms remain in a safe zone.
At-A-Glance Dose Table (Adults And Children)
This table lands early so you can grab the basics fast. The ranges below reflect labeled dosing and common practice in heart failure care.
| Population/Scenario | Starting Dose | Usual Max |
|---|---|---|
| Adult heart failure (sinus rhythm) | 5 mg twice daily with food (or 2.5 mg twice daily in sensitive patients) | 7.5 mg twice daily (15 mg/day) |
| Pediatric ≥1 year (weight-based) | 0.05 mg/kg twice daily | 0.3 mg/kg twice daily (cap 7.5 mg twice daily) |
| Pediatric 6–12 months | 0.05 mg/kg twice daily | 0.2 mg/kg twice daily |
Why these ceilings? Ivabradine lowers heart rate by inhibiting the sinus node’s funny current (If). The goal isn’t “as much as possible.” The goal is a resting heart rate near 50–60 beats per minute without symptoms that hint at over-slowing (dizziness, fatigue, visual brightness phenomena that don’t settle, or true bradycardia). In practice, many patients land at 5 mg twice daily; others reach 7.5 mg twice daily when heart rate remains above target and the drug is well tolerated.
Who Qualifies For Ivabradine And When A Lower Start Fits
Ivabradine supports patients with systolic heart failure who are in sinus rhythm and have an elevated resting heart rate despite guideline-directed therapy. It’s often added when beta-blockers can’t be pushed higher or when rate remains above target. A lower starting dose—2.5 mg twice daily—makes sense if a person has borderline resting heart rate, a history of pauses, or is small, frail, or on multiple heart-rate-lowering drugs.
Food, Timing, And Missed Doses
- With food: Take doses with meals to keep exposure steady.
- Evenly spaced: Aim for morning and evening to cover the day.
- Missed dose: Skip it and take the next one at the regular time; don’t double up.
How Titration Works In Real Life
Two pieces guide dose changes: resting heart rate and how you feel. After about two weeks on a new dose, the prescriber checks resting heart rate. If resting rate stays above target and you feel fine, the dose can rise. If resting rate drifts below about 50 bpm or symptoms hint at over-slowing, the dose steps down. The same rhythm continues until you hit a steady, comfortable range.
Target Heart Rate Window
Most programs aim for a resting heart rate around 50–60 bpm. People differ, so the right number is the one that holds symptoms down while leaving you steady on your feet. If your rate drops under 50 bpm at rest or you feel light-headed, the dose usually backs off.
When Max Dose Isn’t Right
More isn’t always better. Several common situations call for a lower ceiling or even a pause:
- Bradycardia at baseline: If resting heart rate sits near the low 60s or dips lower, the prescriber may stop at 2.5–5 mg twice daily.
- Conduction disease: First-degree block or previous pauses call for a cautious step-up and a lower ceiling.
- Acute decompensation: During a flare of heart failure, rate and blood pressure shift; dose moves wait until things settle.
- New rate-slowing drugs: When a calcium channel blocker like diltiazem or verapamil enters the mix, the ivabradine dose may need to stay put or drop.
- Liver issues: With moderate impairment, exposure rises; dose steps tend to be smaller. Severe impairment is a no-go.
Drug Combos And Interactions That Change The Ceiling
Ivabradine is a CYP3A4 substrate. Strong inhibitors spike levels and are avoided. Moderate inhibitors raise levels enough that many clinicians either lower the dose or choose a different plan. Some drugs also add to heart-rate slowing, which can push you past the safe window.
Common Interaction Patterns
- Strong CYP3A4 inhibitors: Ketoconazole, clarithromycin, certain antivirals. These are generally avoided with ivabradine.
- Moderate CYP3A4 inhibitors: Diltiazem, verapamil, grapefruit juice. These can increase exposure; a lower dose or an alternate therapy may be used.
- Additive rate-slowing: Beta-blockers, amiodarone, digoxin. Combo use is common in heart failure, so titration leans on heart rate checks and symptoms.
- Inducers: Rifampin, carbamazepine, St. John’s wort. These can lower drug levels and blunt effect.
Interaction-Aware Dose Guide
The table below translates the patterns above into simple actions you can review with your prescriber. It’s a quick map, not a substitute for a full check of your medication list.
| Drug Situation | What Usually Happens | Typical Dose Move |
|---|---|---|
| Strong CYP3A4 inhibitor present | Levels rise sharply; risk of bradycardia | Avoid the combo |
| Moderate inhibitor (diltiazem/verapamil) | Levels rise | Prefer an alternative agent or keep ivabradine lower |
| Added beta-blocker uptitration | Extra slowing of heart rate | Hold dose, recheck heart rate before any increase |
Practical Signs You’ve Reached The Right Dose
The “right” dose is the one that meets three checks: symptoms of heart failure ease, resting heart rate sits near the target range on repeated checks, and side effects stay mild or absent. Many people notice better stamina and easier breathing on walks or stairs once the heart rate comes down in a controlled way.
When To Call Your Care Team
- Resting heart rate under 50 bpm, especially with dizziness or fatigue.
- New or worsening flashes of bright spots or halos that don’t fade.
- Any fainting event.
Dosing In Children: Weight-Based Ceilings
For children, weight drives the dose. Many centers start at 0.05 mg/kg twice daily. The usual ceiling is 0.3 mg/kg twice daily for those one year and older, capped at 7.5 mg twice daily. For infants 6–12 months, the ceiling is 0.2 mg/kg twice daily. Because growth and heart rate change over time, follow-up visits and weight checks matter; doses are re-calculated and rounded to available strengths or to the oral solution volume.
Oral Solution Vs. Tablets
Tablets come in 5 mg and 7.5 mg strengths. The oral solution (5 mg/5 mL) helps with smaller or finely tuned doses, especially in pediatrics or in adults who can’t swallow tablets. Food pairing still applies.
What To Expect During The First Month
Here’s a typical cadence many clinics use. Your plan may vary, and that’s fine—the path follows your numbers and how you feel.
Week-By-Week Flow
- Week 0: Start at 5 mg twice daily with meals (or 2.5 mg twice daily if a lower entry suits you).
- Week 2: Recheck resting heart rate and symptoms. If resting rate sits above goal and you feel steady, move toward the next step.
- Week 2–4: If needed, increase to 7.5 mg twice daily. If you hit light-headedness or resting heart rate near the 40s, step back.
- Afterward: Stay at the dose that holds resting heart rate near the 50–60 bpm window with good day-to-day comfort.
Safety Reminders That Affect Dose Decisions
- Pregnancy: Use needs a careful risk-benefit talk; reliable contraception is commonly advised during treatment.
- Atrial fibrillation: The drug targets the sinus node. If rhythm changes away from sinus, the effect drops; dose plans may change.
- Pacemaker: If pacing drives the rhythm, rate-lowering benefit may be limited.
Angina Use Outside The U.S.
In some regions, ivabradine is also used for chronic stable angina. Dosing still centers on 5 mg twice daily with a possible rise to 7.5 mg twice daily, guided by heart rate and symptoms. Local product information governs those decisions.
Two Authoritative Sources You Can Read
For dose ceilings, pediatric ranges, missed-dose language, and interaction cautions, see the FDA prescribing information. For who benefits and where this drug fits in the bigger therapy picture, see the AHA/ACC/HFSA heart failure guideline.
Quick Answers To Dose-Setting Questions
What If My Resting Heart Rate Is Still High?
If resting heart rate stays above target after two weeks and you feel well, your prescriber can increase the dose stepwise up to the usual ceiling. The check is repeated after each change.
What If My Resting Heart Rate Falls Too Low?
The dose comes down. If you hit the lowest dose and still sit under the safe range, the drug may be stopped and the plan reworked.
Can I Take It With A Beta-Blocker?
Yes. The combo is common in heart failure care. Dose moves stay small and steady because both drugs slow the heart.
Does Food Matter?
Yes—pair with meals to keep levels stable and to match how the drug was studied.
Bottom Line Dose Map
Adults usually start at 5 mg twice daily and rise to 7.5 mg twice daily only if resting heart rate remains above goal and the drug feels smooth. Some adults begin at 2.5 mg twice daily. Children use weight-based math with caps by age. Interacting drugs, rhythm changes, and side effects can lower the ceiling. The aim is not the largest number; it’s the dose that steadies heart rate in the 50–60 bpm range and helps you feel better day to day.